Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Leukemia, Myeloid, Acute 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 116Myelodysplastic Syndromes 112Leukemia, Lymphocytic, Chronic, B-Cell 102Lymphoma, Non-Hodgkin 98Hodgkin Disease 95Leukemia 86Multiple Myeloma 85Lymphoma 72Lymphoma, Mantle-Cell 67Lymphoma, Follicular 67Lymphoma, Large B-Cell, Diffuse 64Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 58Burkitt Lymphoma 53Leukemia, Myelomonocytic, Chronic 51Congenital Abnormalities 51Leukemia, Myeloid, Chronic-Phase 49Lymphoma, Large-Cell, Immunoblastic 46Leukemia, Myeloid, Accelerated Phase 43Hematologic Neoplasms 42Anemia, Refractory, with Excess of Blasts 40Graft vs Host Disease 39Primary Myelofibrosis 36Waldenstrom Macroglobulinemia 34Neoplasms, Plasma Cell 33Blast Crisis 33Recurrence 30Lymphoma, T-Cell, Cutaneous 30

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 136Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 68fludarabine phosphate 62Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Specimen Handling 36Cisplatin 36CTLA-4 Antigen 36Magnetic Resonance Spectroscopy 35Carboplatin 35cobimetinib 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Mycophenolic Acid × Clear all
NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting
112 enrolled
Dermatologic

Colitis, Hepatitis, Melanoma

NCT00006233 2011-11-30

Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma

Fred Hutchinson Cancer Center

Phase 2 Completed
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡